The role of opioid substitution treatment in reducing HIV transmission: Risks for drug users and the wider community are substantially reduced

BMJ (Online)

Volumn 345, Issue 7879, 2012, Pages

  Gowing, Linda R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIRETROVIRUS AGENT; BUPRENORPHINE; COCAINE; METHADONE; OPIATE;

DRUG DEPENDENCE; EDITORIAL; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INTRAVENOUS DRUG ABUSE; OPIATE SUBSTITUTION TREATMENT; ORAL SEXUAL CONTACT; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW (TOPIC); VIRUS LOAD; VIRUS TRANSMISSION;

HIV INFECTIONS; HUMANS; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84867785445     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e6425     Document Type: Editorial

References (10)

1. MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012;345:e5945.
2. Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2011;8:CD004145.
3. Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 2008;103:1242-57. (Pubitemid 352009054)
4. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 2010;376:285-301.
5. Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C Virus infection in people who inject drugs. J Infect Dis 2011;204:74-83.
6. Farrell M, Wodak A, Gowing L. Maintenance drugs to treat opioid dependence. BMJ 2012;344:e2823.
7. Des Jarlais DC, Arasteh K, McKnight C, Hagan H, et al. Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health 2011;101:1277-83.
8. El-Guebaly N. The meanings of recovery from addiction: evolution and promises. J Addict Med 2012;6:1-9.
9. Kalant H. What neurobiology cannot tell us about addiction. Addiction 2010;105:780-9.
10. Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ 2005;14:1133-50. (Pubitemid 41645377)